GLP-1 Discontinuation: Real-World Perspectives on a Complex Journey
Omada Insights Lab surveyed and interviewed Omada members with a history of GLP-1 use to learn more about their unique needs and experiences.
Read Resource
Latest Content
Roundup of most recently released content and assets.
-
-
Omada Health GLP-1 Care Track
Learn More -
Omada Health Publishes Findings from Consumer Survey of GLP-1 Users
Survey finds only 18% of respondents who discontinued GLP-1s achieved their weight loss goals; respondents want to lose an average of 22% more weight.
Read Article
-
The 28 Billion Dollar Reason Heart Health Matters in Women Post-menopause
Cardiovascular disease (CVD) remains the leading cause of death among women, yet it is often misdiagnosed and/or undertreated. Join the discussion on the need for more focus on women's heart health.
Watch Video
-
The GLP-1 Journey
New consumer data indicates that sustaining weight loss and overall well-being requires intervention beyond the GLP-1
Read Resource
-
Whole-Person Well-Being Over Profits
Return on Health Framework for Realizing the Value of Virtual Care
Read Resource
-
Anne Beal, MD, MPH Joins Omada Health Board of Directors
Dr. Beal brings extensive experience in clinical innovation, patient advocacy, and population health to Omada’s Board.
Read Article
-
The Problem with BMI: Addressing Inequities in Obesity Screening
With its checkered past and at times questioned clinical merits, BMI’s ubiquity in modern healthcare should be carefully considered.
Read Resource
-
New GLP-1 Indications: What you need to know
This insightful webinar delves into the expanding role of GLP-1 medications in treating a wide range of chronic conditions beyond diabetes and obesity.
Watch Video
-
Omada Health adds Sachin Jain, M.D., MBA, Julie Klapstein and Adam Stavisky to Board of Directors
New board members provide deep clinical and commercial experience.
Read Article
-
Omada Health’s Guide to GLP-1s | Q3 - Q4 2024
Omada drills into emerging details of the GLP-1 experience, including compounded GLP-1s, how to manage the drug’s impact on body composition, & ways to assess the value of virtual companion programs.
Read Article
-
Using AI to Strengthen Human Relationships: Q&A with Terry Miller, VP of Machine Learning, AI and Data Science Strategy
Q&A with Terry Miller, VP of Machine Learning, AI and Data Science Strategy
Read Article
-
Economic Savings Model for Omada’s Cardiometabolic Programs
Economic Savings Model for Omada’s Cardiometabolic Programs
Read Article
-
Omada Joins Pledge to White House-Supported Healthcare AI Commitments
Company pledges to keep humans at the center of care.
Read Article
-
Omada Health's Journey with Artificial Intelligence
How Data Science and AI learnings surprised us, taught us, and propelled us forward.
Read Article
-
Life With GLP-1s
Clinical and cultural conversations around obesity have long revolved around BMI (and its credibility), harmful stereotypes, issues of equity and the multi-million dollar weight loss industry.
Read Resource
-
How to Combat Muscle Loss While Taking GLP-1s
A side-effect of taking GLP-1s is a loss of muscle mass. Julie Mulcahy, PT, DPT, CAPP OB explores how to combat this with resistance exercises.
Read Article
-
Omada Health GLP-1 Care Track
Learn More -
New Research Shows Long-Term A1C Reduction and Sustained Weight Maintenance for Members in Omada Health’s Type 2 Diabetes Program
Omada Health, the virtual-first healthcare provider, published its 28th peer-reviewed study demonstrating the long-term outcomes of utilizing a behavior change program for members with type 2 diabetes
Read Article
-
The Science Behind Dieting, and Why it Doesn’t Work
Lisa McCormick, FNP-BC, RD, CDCES explores the science behind dieting and why it doesn't work. Find out more about sustainable weight loss!
Read Article
-
New Data Published by Omada Health Demonstrates the Impact of Coupling GLP-1s and Behavior Change Programming
Findings show that meaningfully engaged Omada members on GLP-1s achieved an average of 1.7 times greater weight loss, and inform a new collaboration with Evernorth's EncircleRx program.
Read Article
-
NEBGH: 13th Annual Health and Wellness Benefits Conference
Leading Innovation at NEBGH 13th Annual Health and Wellness Benefits Conference
Read Article
-
Loading More...
